Exeter Headache Clinic

Statement on the use of Triptans in Pregnancy

Home
Educational Video Links for Doctors and Patients
Patient Information Sheets
Management Guidelines
Migraine Handbook for Self Management
Research Activity and Publications
Education
Support for NHS Commissioners
School Policy Guidance
BASH GPwSI Meeting Presentations
Proposed NHS Devon Headache Referral Guidelines
Headache Support Groups
Contact us
How to find us
Statement on Transcranial Magnetic Stimulation
Statement on the use of Triptans in Pregnancy
Information for Prescribing Doctors for: Ordering Oxygen and Prescribing Flunarizine
Statement on the use of Triptans in Pregnancy
The NICE Headache Guidelines have stated that a Triptan can be considered and a recently published retrospective database showed no increase in birth defects above the natural background rate in pregnant women who are taking Sumatriptan.  If drugs that are known to be safe during pregnancy are not effective, then the benefits of Sumatriptan should be discussed against the potential risks of using any drug in pregnancy against a background of this reassuring data.  If Triptans are to be used, then the patient should issue written consent along the prescribing guidelines.  It would be sensible to avoid use in the first Trimester.

October 2014